Health Care & Life Sciences » Biotechnology | bioMmune Technologies Inc.

bioMmune Technologies Inc. | Key People and Executives

Karoly Nikolich
Chairman
Patrick W. Gray
President, Chief Executive Officer & Director
Julie M. Eastland
Director
Graeme I. Bell
Independent Director
Thomas R. Gadek
Independent Director
Jens Biertumpel
Independent Director
Terry W. Pearson
Independent Director
Karoly Nikolich
Chairman
Patrick W. Gray
President, Chief Executive Officer & Director
Judi Dalling
Chief Financial Officer & Secretary
Julie M. Eastland
Director
Graeme I. Bell
Independent Director
Thomas R. Gadek
Independent Director
Jens Biertumpel
Independent Director
Terry W. Pearson
Independent Director

About bioMmune Technologies

View Profile
Address
400 Burrard Street
Vancouver British Columbia V6C 3A6
Canada
Employees -
Website http://www.pascalbiosciences.com
Updated 07/08/2019
Pascal Biosciences Inc. is a biotechnology company, which engages in developing breakthrough treatments in the field of immuno-oncology. It focuses on the following technologies: Major Histocompatibility Complex I (MHC I), CD74 and Calcium Channel Blockers. The MHC I technology is a molecule that transports normal, abnormal and foreign protein fragments (peptides) to the surface of the cells where the fragments are then exposed to the immune system's T cells.